Microbial Fermentation Technology Market Trends/Analysis Report 2022 – ResearchAndMarkets.com

Microbial Fermentation Technology Market Trends/Analysis Report 2022 – ResearchAndMarkets.com

Microbial Fermentation Technology Market Trends/Analysis Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Microbial Fermentation Technology Market Size, Share & Trends Analysis Report by Application (Antibiotics, Vaccines), by End-use (Biopharmaceutical Companies), by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.

The global microbial fermentation technology market size is expected to reach USD 49.4 billion by 2030 and is expected to expand at a CAGR of 6.0% from 2022 to 2030

Since fermentation is observed to be of utmost importance in the manufacturing of biopharmaceuticals, there is also a growing demand for microbial fermentation technology in biopharmaceutical manufacturing. This has led to increasing collaborations and developments in this market space.

For instance, in September 2021, BIOVECTRA and ABEC collaboratively announced that the latter company would provide CSR single-use microbial fermentation solutions to expand BIOVECTRA’s manufacturing capabilities. The newly installed solutions are expected to provide a faster turnaround time with high-growth microbial fermentation on large scale.

Moreover, in September 2022, Cargill and Genomatica along with Cyclone Engineers are working on a project to scale up the bioreactor fermentation processing. This project is a part of the National Biotechnology and Biomanufacturing Initiative with a grant of USD 2.5 million.

Furthermore, technological advances in microbial fermentation platforms are also expected to supplement the market growth. For instance, several metabolic engineering approaches have been developed by researchers to enhance the performance of microbial cell factories used for the production of complex biologics or small molecules. Such continuous developments in this market space are likely to increase the adoption of this technology in biomanufacturing.

Additionally, various medications and vaccines, such as hormones, antibody fragments, and pneumococcal vaccines, are bio-manufactured using microbial fermentation techniques. Bacterial cells are often resistant to shear damage, enabling the use of high-shear radial impeller systems and high agitation rates.

This gives the fermentors a high mass transfer potential, allowing them to accommodate fast metabolizing, high-cell density microbial cell cultivations and increasing the quantity of product that the bioprocesses can produce. Thus, with the increasing adoption of SUB fermentors for bacterial fermentation, the market is likely to witness significant growth in the coming years.

Microbial Fermentation Technology Market Report Highlights

  • Based on application, the antibiotics segment captured the highest market revenue share in 2021. Increasing research activities due to the rise of antibiotic-resistant microbes have positively impacted market growth
  • Owing to the faster and stable growth pattern of microorganisms, the use of fermentation in small molecule synthesis is expected to witness a lucrative growth throughout the forecast period
  • By end-users, CMOs and CDMOs accounted for a significant share in 2021. The capacity expansion by several CMOs and the growing trend of outsourcing are expected to propel the segment revenue generation
  • Asia Pacific dominated the market in 2021 owing to the high number of operating CMOs and growing biopharmaceutical industry in countries such as India, Japan, and China
  • Furthermore, the demand for biologics and biopharmaceuticals is increasing in Japan. As a result, Japanese firms are undertaking various strategic initiatives to enhance their domestic biomanufacturing operations
  • North America is anticipated to witness the fastest growth throughout the forecast period owing to the presence of a well-established biopharmaceutical industry coupled with a high number of fermentation solution providers
  • Continuous efforts by key players to improve their product offerings are also contributing to North America’s regional market growth

Market Variables, Trends, & Scope

Market Driver Analysis

  • Increasing usage of fermentation technology-derived products among various industries
  • Rising research and development activities in different fields of fermentation technology
  • Exhausting fossil fuel reserves and rising gasoline prices

Market Restraint Analysis

  • Technological challenges associated with microbial fermentation

Penetration and Growth Prospect Mapping for Application, 2021 (USD Million)

COVID-19 Impact Analysis

Business Environment Analysis

  • SWOT analysis; by factor (political & legal, economic, and technological)
  • Porter’s five forces analysis

Company Profiles

  • Biocon Ltd.
  • Biovectra Inc.
  • Danone UK
  • F. Hoffmann-La Roche Ltd
  • Koninklijke Dsm Nv
  • Lonza
  • Novozymes A/S
  • Terravia Holdings, Inc.
  • Biozeen

For more information about this report visit https://www.researchandmarkets.com/r/bj3loi



Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900